These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 23389386

  • 1. Thrombolysis in ischemic stroke patients on treatment with Dabigatran.
    Re G, Toni D.
    Intern Emerg Med; 2013 Aug; 8(5):451-2. PubMed ID: 23389386
    [No Abstract] [Full Text] [Related]

  • 2. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M, Szkotak A, Witt A, Shuaib A, Butcher K.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [Abstract] [Full Text] [Related]

  • 3. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV, Zateĭshchikov DA.
    Kardiologiia; 2014 Jul; 54(2):79-85. PubMed ID: 24888206
    [No Abstract] [Full Text] [Related]

  • 4. Stroke thrombolysis in patients taking dabigatran.
    Jayathissa S, Gommans J, Harper P.
    Intern Med J; 2013 Jul; 43(7):826-8. PubMed ID: 23841763
    [Abstract] [Full Text] [Related]

  • 5. Dabigatran - neurosurgical anathema?
    Thomas PA, Schaerf NB, Rosenfeld JV.
    Med J Aust; 2013 Aug 19; 199(4):238-40. PubMed ID: 23984772
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
    Rybinnik I, Mullen MT, Messe S, Kasner SE, Cucchiara B.
    J Stroke Cerebrovasc Dis; 2013 Nov 19; 22(8):1312-6. PubMed ID: 23313461
    [Abstract] [Full Text] [Related]

  • 7. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C, Duarte J, Sobral S, Pestana P, Nzwalo H, Rita H, Sousa E Costa J.
    Am J Emerg Med; 2014 Nov 19; 32(11):1435.e1-2. PubMed ID: 24881517
    [Abstract] [Full Text] [Related]

  • 8. Reversible Cognitive Impairment Associated with the Use of Dabigatran.
    La Brooy B, Ho P, Lim K.
    J Am Geriatr Soc; 2015 Aug 19; 63(8):1717-9. PubMed ID: 26289705
    [No Abstract] [Full Text] [Related]

  • 9. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
    Gagliardi L, Guerbaai RA, Marlière S, Bouvaist H, Ennezat PV.
    Int J Cardiol; 2014 Aug 20; 175(3):571-2. PubMed ID: 24861253
    [No Abstract] [Full Text] [Related]

  • 10. Using dabigatran in patients with stroke: a practical guide for clinicians.
    Alberts MJ, Bernstein RA, Naccarelli GV, Garcia DA.
    Stroke; 2012 Jan 20; 43(1):271-9. PubMed ID: 22156688
    [No Abstract] [Full Text] [Related]

  • 11. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
    Matute MC, Guillán M, García-Caldentey J, Buisan J, Aparicio M, Masjuan J, Alonso de Leciñana M.
    Thromb Haemost; 2011 Jul 20; 106(1):178-9. PubMed ID: 21505718
    [No Abstract] [Full Text] [Related]

  • 12. Dabigatran: will it change clinical practice?
    Wartak SA, Bartholomew JR.
    Cleve Clin J Med; 2011 Oct 20; 78(10):657-64. PubMed ID: 21968472
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
    Gunes F, Asik M, Temiz A, Binnetoglu E, Sen H, Bilen Oİ, Akbal E, Adam G, Ukinc K.
    Wien Klin Wochenschr; 2014 Jan 20; 126(1-2):62-3. PubMed ID: 24240609
    [No Abstract] [Full Text] [Related]

  • 14. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
    Stöllberger C, Rakusan S, Wimpissinger FT, Finsterer J.
    Thromb Haemost; 2012 Sep 20; 108(3):579-81. PubMed ID: 22739630
    [No Abstract] [Full Text] [Related]

  • 15. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012 Sep 20; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 16. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Jan 20; 92(1):46-53. PubMed ID: 24265137
    [Abstract] [Full Text] [Related]

  • 17. [Advantages of NOAKs validated in clinical routine].
    Ameri AA.
    MMW Fortschr Med; 2015 May 13; 157(9):70. PubMed ID: 26012835
    [No Abstract] [Full Text] [Related]

  • 18. What is the role of renal replacement therapy in the setting of dabigatran toxicity?
    Ghannoum M, Nolin TD.
    Semin Dial; 2014 May 13; 27(3):223-6. PubMed ID: 24620942
    [No Abstract] [Full Text] [Related]

  • 19. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
    Buch TN, Holm J, Munck LK.
    Ugeskr Laeger; 2013 Feb 04; 175(6):333-4. PubMed ID: 23402235
    [Abstract] [Full Text] [Related]

  • 20. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.